Cardiff Share Price

Cardiff Share Price

NASDAQ: CRDF | Micro Cap | Healthcare
$0.86
-$0.03 (-3.32%) Last updated on 21 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • Corporate Actions
  • About
  • Price history
  • FAQs

Cardiff Stock Performance

Open
$0.90
Prev. Close
$0.88
Circuit Range
N/A
Day Range
$0.84 - $0.90
Year Range
$0.72 - $3.31
Volume
7,588
Average Traded
$0.86

Cardiff Share Price Today

As of 22 November 2026, Cardiff Oncology, Inc.'s share price is $0.86. The stock opened at $0.90, compared to its previous close of $0.88. During today's trading session, Cardiff Oncology, Inc.'s share price traded between $0.84 and $0.90, with an average price of $0.87. Over the past 52 weeks, the stock has recorded a high of $3.31 and a low of $0.72. In terms of performance, Cardiff Oncology, Inc.'s share price has declined by 55.21% over the last six months and is down 62.48% on a year-on-year basis.

Cardiff Share Price Chart

Line chart of the Cardiff price trend over the selected period. The price fell overall, ranging from 0.83 to 0.90, ending at 0.85.
$0.84$0.90
L
Show Current Price
H

Cardiff Stock Fundamentals & Key Indicators

Market Cap
$57.18M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.48
Revenue (TTM)
$590.00M
Return On Equity (TTM)
-134.06%
Profit Margin
-7776.27%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-22.71%

Cardiff Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$0.24$0.04$0.10$0.17
Net Profit-$7.22-$12.35-$9.24-$8.86
Net Profit Margin-3008.33%-30875.00%-9240.00%-5211.76%
Income ChangeN/A-71.05%25.18%4.11%

Cardiff Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.39$0.49$0.68$0.59
Net Profit-$38.73-$41.47-$45.46-$45.88
Net Profit Margin-9930.77%-8463.27%-6685.29%-7776.27%
Income ChangeN/A-7.07%-9.62%-0.92%

Cardiff Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets1.762.144.234.91
Current Assets60.1395.0577.41111.28
Total Assets61.8897.1981.64116.19
Non Current Liabilities0.10.811.462.04
Current Liabilities16.3913.4310.447.81
Total Liabilities16.514.2411.99.85
Shareholders' Equity45.3982.9569.74106.34

Cardiff Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-37.92-37.69-30.89-33.82
Investing1.3413.7336.238.15
Financing2.5853.780.00.08

Corporate Actions

Split
Ex-date: 20 Feb 2019

Split
Ex-date: 04 Jun 2018

About Cardiff

Cardiff Oncology Inc is a clinical-stage biotechnology company advancing cancer treatments focused on PLK1 inhibition, a validated oncology target with practice-changing potential. Its main asset, onvansertib, is a specific, oral PLK1 inhibitor currently being evaluated in a Phase 2 trial for first-line treatment of RAS-mutated metastatic colorectal cancer (mCRC), addressing a large, underserved patient population with high unmet need. Onvansertib is also under investigation in other PLK1-driven cancers through ongoing investigator-initiated trials and has shown robust single agent clinical activity in hard-to-treat tumors. By targeting tumor vulnerabilities, to overcome treatment resistance and deliver improved clinical outcomes for patients.

Cardiff Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$0.89
$0.85
-1.72%
Oct 2026
$1.20
$0.87
-27.50%
Sep 2026
$1.02
$1.20
+21.46%
Aug 2026
$0.87
$0.99
+14.88%
Jul 2026
$1.29
$0.86
-33.59%
Jun 2026
$1.68
$1.29
-32.20%
May 2026
$1.74
$1.91
+10.72%
Apr 2026
$1.69
$1.73
+6.15%
Mar 2026
$1.87
$1.63
-15.80%
Feb 2026
$1.70
$1.93
+10.92%
Jan 2026
$2.79
$1.74
-37.97%
Dec 2025
$2.25
$2.81
+23.03%

Cardiff Share Price FAQs